Serum Institute of India's new 'high efficacy' malaria vaccine rolls out in Africa

Daily Current Affairs / Serum Institute of India's new 'high efficacy' malaria vaccine rolls out in Africa

Change Language English Hindi

Category : National Published on: July 17 2024

Share on facebook

The Serum Institute of India (SII) and Oxford University launched the high-efficacy malaria vaccine R21/Matrix-M in Cote d'Ivoire, priced under $4 per dose and approved by WHO.
SII plans to produce 100 million doses annually, with the vaccine also authorized in Ghana, Nigeria, Burkina Faso, and the Central African Republic, aiming to reduce malaria deaths in Africa.

Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....
Weekly Current Affairs (1st September to 7th September 2024)
Read More....

Serum Institute of India's new 'high efficacy' malaria vaccine rolls out in Africa